Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alicia Le Bras"'
Autor:
Isabelle Durand-Zaleski, Mohaned Egred, Adrian P Banning, David Hildick-Smith, Marie-Claude Morice, Philippe Brunel, Alicia Le Bras, Arnaud Nze Ossima, Olivier Supplisson
Publikováno v:
Open Heart, Vol 11, Iss 1 (2024)
Background In patients with distal bifurcation left main stem lesions requiring intervention, the European Bifurcation Club Left Main Coronary Stent Study trial found a non-significant difference in major adverse cardiac events (MACEs, composite of a
Externí odkaz:
https://doaj.org/article/026286fbc0c4444a9bd25d146060bf5b
Publikováno v:
One Health, Vol 15, Iss , Pp 100408- (2022)
The annual incidence of rabies deaths has been estimated in Cambodia at nearly 5.8/100,000 person-years. The cost of post exposure prophylaxis (PEP) and travel is potentially a significant barrier for exposed patients and their families, although saf
Externí odkaz:
https://doaj.org/article/170012ad033e4191958100b60c80705a
Autor:
Alicia Le Bras, Yazid Belkacemi, céline Bourgier, Isabelle Gabelle-Flandin, Adeline Petit, Philippe Guilbert, Julien Geffrelot, Christian Carrie, Eleonor RIVIN DEL CAMPO, Chantal Hanzen, claire charra-brunaud, Guillaume Auzac, Thomas Lacornerie, Jérôme Lemonnier, Eric Lartigau, Isabelle Durand-Zaleski
Publikováno v:
Cancer Research. 83:P1-10
Purpose: The economic evaluation reports the incremental cost utility ratio and budget impact of APBI vs standard external beam WBI for the treatment of post-menopausal women with early stage breast cancer. Methods and materials: We compared 488 wome
Autor:
Victoria Tea, Jean-François Morelle, Romain Gallet, Guillaume Cayla, Gilles Lemesle, Thibault Lhermusier, Jean-Guillaume Dillinger, Grégory Ducrocq, Denis Angouvant, Yves Cottin, Chekrallah Chamandi, Alicia le Bras, Philippe Gabriel Steg, Gilles Montalescot, Anaïs Charles Nelson, Tabassome Simon, Gilles Chatellier, Nicolas Danchin, Etienne Puymirat
Publikováno v:
Archives of cardiovascular diseases
Archives of cardiovascular diseases, 2022, 115 (10), pp.496-504. ⟨10.1016/j.acvd.2022.05.011⟩
Archives of cardiovascular diseases, 2022, 115 (10), pp.496-504. ⟨10.1016/j.acvd.2022.05.011⟩
International audience; Background: in patients with ST-segment elevation myocardial infarction and multivessel disease, percutaneous coronary intervention for non-culprit lesions is superior to treatment of the culprit lesion alone. The optimal timi
Autor:
Alicia Le Bras, Etienne Puymirat, Hasina Rabetrano, Guillaume Cayla, Tabassome Simon, Gabriel Steg, Gilles Montalescot, Olivier Varenne, Laurent Bonello, Pierre Coste, Nicolas Delarche, Jean-Louis Georges, Stephan Chassaing, Vincent Letocart, Gilles Chatellier, Nicolas Danchin, Isabelle Durand-Zaleski
Publikováno v:
EuroIntervention
EuroIntervention, 2022, 18 (3), pp.235-241. ⟨10.4244/EIJ-D-21-00867⟩
EuroIntervention, 2022, 18 (3), pp.235-241. ⟨10.4244/EIJ-D-21-00867⟩
International audience; Background: In patients with ST-segment elevation myocardial infarction (STEMI) who have multivessel disease, the FLOWER-MI trial found no significant clinical benefit to fractional flow reserve (FFR)-guided percutaneous coron
Autor:
Alicia Le Bras, Philippe Gabriel Steg, Gilles Montalescot, Tabassome Simon, Isabelle Durand-Zaleski, Hervé Le Breton, Francois Schiele, Gérald Vanzetto, Nicolas Danchin, Yann Valy, Denis Angoulvant, Pierre Denormandie, François Roubille, Etienne Puymirat, Gilles Chatellier, Pascal Goube, Guillaume Cayla, Thomas Cuisset, Anaïs Charles-Nelson, Sébastien Levesque, O. Nallet
Publikováno v:
Circulation: Cardiovascular Interventions
Circulation: Cardiovascular Interventions, 2021, 14 (11), pp.e011314. ⟨10.1161/CIRCINTERVENTIONS.121.011314⟩
Circulation: Cardiovascular Interventions, American Heart Association, 2021, ⟨10.1161/CIRCINTERVENTIONS.121.011314⟩
Circulation: Cardiovascular Interventions, 2021, 14 (11), pp.e011314. ⟨10.1161/CIRCINTERVENTIONS.121.011314⟩
Circulation: Cardiovascular Interventions, American Heart Association, 2021, ⟨10.1161/CIRCINTERVENTIONS.121.011314⟩
Background: In patients with ST-segment–elevation myocardial infarction and multivessel disease, percutaneous coronary intervention (PCI) for nonculprit lesions guided by fractional flow reserve (FFR) is superior to treatment of the culprit lesion
Autor:
Etienne, Puymirat, Guillaume, Cayla, Tabassome, Simon, Philippe G, Steg, Gilles, Montalescot, Isabelle, Durand-Zaleski, Alicia, le Bras, Romain, Gallet, Khalife, Khalife, Jean-François, Morelle, Pascal, Motreff, Gilles, Lemesle, Jean-Guillaume, Dillinger, Thibault, Lhermusier, Johanne, Silvain, Vincent, Roule, Jean-Noel, Labèque, Grégoire, Rangé, Grégory, Ducrocq, Yves, Cottin, Didier, Blanchard, Anaïs, Charles Nelson, Bernard, De Bruyne, Gilles, Chatellier, Nicolas, Danchin, Sebastien, Levesque
Publikováno v:
The New England journal of medicine. 385(4)
In patients with ST-elevation myocardial infarction (STEMI) who have multivessel disease, percutaneous coronary intervention (PCI) for nonculprit lesions (complete revascularization) is superior to treatment of the culprit lesion alone. However, whet
Publikováno v:
SSRN Electronic Journal.
Background: The annual incidence of rabies deaths has been estimated in Cambodia at nearly 5•8/100,000 person-years. The cost of post exposure prophylaxis (PEP) and travel is potentially a significant barrier for exposed patients and their families
Autor:
Annalisa, Montante, Alicia, Le Bras, Christian, Pagnoux, Elodie, Perrodeau, Philippe, Ravaud, Benjamin, Terrier, Loïc, Guillevin, Isabelle, Durand-Zaleski
Publikováno v:
Clinical and experimental rheumatology. 37(2)
Rituximab was proven superior to azathioprine for maintenance treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The high cost of rituximab might, however, limit its routine use. This study determined the cost-effect